U.S. Facing Severe Shortage of Infectious Disease Physicians
In light of the COVID-19 pandemic, there has been a focus on the shortage of doctors opting to specialize in infectious disease. According to forecasts by the U.S. Health Resources and Services Administration (HRSA), the United States will face a serious shortage of infectious disease doctors with estimates showing that that by 2035 there will […]
Trust “The Science”? No.
Thanksgiving weekend came and went in 2021. The soothsayers of Team Apocalypse were wrong again—the sky didn’t fall. Whole populations of families who dared to get together to celebrate were not wiped out. But that didn’t stop NIAID Director Dr. Anthony Fauci. The COVID fatality rate doesn’t hold a candle to the risk of standing […]
Monoclonal Antibodies No Longer Effective Against New Strains of SARS-CoV-2
Monoclonal antibodies, which are synthetic versions of antibodies that are produced in a lab, appear to have lost effectiveness against COVID-19 disease as new variants of the virus emerge. Previously touted as the top-of-the-line outpatient treatment by public health officials and many clinicians, monoclonal antibodies have fallen out of favor as outpatient treatment for patients […]
Sen. Ron Johnson on Forcing People to Take a COVID Vaccine That Does Not Prevent Infection or Transmission
The bottom line is the [COVID-19] vaccine does not prevent infection, it does not prevent transmission. So why would we make anybody take it? It is insane. We force people to take a vaccine that doesn’t prevent infection or transmission… again, it’s an insane policy. … I’m going to speak on behalf of those who […]
Pfizer’s New RSV Vaccine for Pregnant Women on Fast Track
Amongst frantic media coverage of increases in cases of (RSV) among children, Pfizer has announced the development of an experimental bivalent RSV vaccine for pregnant mothers in an attempt to protect newborns from being infected with the virus. The pharmaceutical giant plans to submit the results of their RSV vaccine clinical trials to the U.S. […]
Shortage of Adderall Affecting Behavior in Children and Adults
On October 12, 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of a drug formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall. Adderall is an FDA approved drug for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD), including anger, anxiety, forgetfulness and trouble focusing.1 Adderall […]